After Viagra, Indians may pop Caduet

After Viagra, Pfizer is planning bringing another of its blockbuster drugs to India.Caduet, a new generation cardiovascular drug, is a combination of Lipitor (atorvastatin calcium) and Norvasc......

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune. Wyeth and its new......

Indian retail drug sales jump 10% amid slowdown

Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions......